Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02907073 · ClinicalTrials.gov registry record · Phase 1
Positron Emission Tomography (PET) Imaging Studies With NIS Reporter
A Phase 1 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT02907073: Clinical Trial Phase 1 study, sponsored by Mayo Clinic.
NCT02907073 is a Phase 1 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02907073, a Phase 1 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
The goal of this proposal is to perform first-in-man evaluation of and experimental imaging agent F-18 tetrafluoroborate (BF4) or (TFB).
Interventions
- DRUG BF4
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02907073
The ClinicalTrials.gov registry entry for NCT02907073 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BF4 is the first listed.
NCT02907073 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02907073 about?
NCT02907073 is a clinical study titled "Positron Emission Tomography (PET) Imaging Studies With NIS Reporter". The goal of this proposal is to perform first-in-man evaluation of and experimental imaging agent F-18 tetrafluoroborate (BF4) or (TFB).
What is the current status of trial NCT02907073?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2016-09. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02907073?
The interventions under investigation include: BF4 (DRUG).
Who is sponsoring clinical trial NCT02907073?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.